MET and breast cancer: While c-MET protein overexpression is frequently observed in various cancers and linked to poor prognosis, its functional relevance in the absence of a genomic alteration (like gene amplification or mutation) remains a subject of ongoing research and is not fully understood, through either paracrine or autocrine signaling, the pathway is important for breast cancer progression.